HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chanda, J. Articles by Abe, T. Search for Related Content PubMed PubMed Citation Articles by Chanda, J. Articles by Abe, T.

J Thorac Cardiovasc Surg 1997;114:218-223
© 1997 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

NEW-GENERATION VALVED CONDUIT: AN EXPERIMENTAL STUDY

Received for publication Sept. 30, 1996 Revisions requested Dec. 9, 1996; revisions received Dec. 26, 1996 Accepted for publication Feb. 21, 1997. Address for reprints: Jyotirmay Chanda, MD, Department of Cardiovascular Surgery, Akita University School of Medicine, Akita 010, Japan.

Abstract

Objective: An ideal valved conduit to repair complex congenital heart defects is yet to be developed. In this study we have evaluated the merits of our newly developed calcification-free biologic valve incorporated in a compatible conduit of biologic origin in an animal model. Methods:  Porcine aortic valves and main pulmonary arteries were cross-linked in glutaraldehyde, followed by coupling to partially degraded heparin through an intermediate surface-bound substrate containing amino groups. Because commercially available valves are treated only with glutaraldehyde, control aortic valves and main pulmonary arteries were cross-linked in 0.625% glutaraldehyde. Valved conduits were fabricated from main pulmonary arteries, which were sewn to the aortic and ventricular ends of aortic valves. Valved conduits were examined for calcification and other pathologic changes after being implanted in the descending thoracic aorta in juvenile sheep for 5 months. Results:  Severe calcification was noticed in all layers of cusps (calcium, 231.86 ± 17.90 mg/gm) and aortic wall (calcium, 123.24 ± 24.72 mg/gm) of aortic valves and main pulmonary arteries (calcium, 135.43 ± 26.63 mg/gm) of valved conduits treated with 0.625% glutaraldehyde. Cusps (calcium, 1.28 ± 0.22 mg/gm) of the aortic valve of heparin-bonded conduits did not calcify at all. Only sparse calcific deposits were noticed in the medial layer of the aortic wall (calcium, 25.90 ± 22.79 mg/gm) of aortic valves and main pulmonary arteries (calcium, 9.64 ± 10.79 mg/gm) of the valved conduits coupled to heparin. Conclusion:  Heparin coupling is effective in preventing calcification of glutaraldehyde cross-linked valved conduits implanted in the systemic circulation of juvenile sheep. J Thorac Cardiovasc Surg 1997;114:218-23

This article has been cited by other articles:

				B. Chiappini, C. Barrea, and J. Rubay Right Ventricular Outflow Tract Reconstruction With Contegra Monocuspid Transannular Patch in Tetralogy of Fallot Ann. Thorac. Surg., January 1, 2007; 83(1): 185 - 187. [Abstract] [Full Text] [PDF]

				V. Gober, P. Berdat, M. Pavlovic, J.-P. Pfammatter, and T. P. Carrel Adverse Mid-Term Outcome Following RVOT Reconstruction Using the Contegra Valved Bovine Jugular Vein Ann. Thorac. Surg., February 1, 2005; 79(2): 625 - 631. [Abstract] [Full Text] [PDF]

				A. F. Corno, S. D. Qanadli, N. Sekarski, S. Artemisia, M. Hurni, P. Tozzi, and L. K. von Segesser Bovine Valved Xenograft in Pulmonary Position: Medium-Term Follow-Up With Excellent Hemodynamics and Freedom From Calcification Ann. Thorac. Surg., October 1, 2004; 78(4): 1382 - 1388. [Abstract] [Full Text] [PDF]

				Y. Goto Should the anticalcification effect of epoxy compound in vascular bioprostheses be judged after implantation in mongrel dogs? J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 960 - 961. [Full Text]